• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读262例子宫肉瘤的分子图谱:子宫内膜间质肉瘤、类似卵巢性索肿瘤的子宫肿瘤及未分化子宫肉瘤的RNA测序聚类分析与预后洞察

Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.

作者信息

Hojný Jan, Dvořák Jiří, Vránková Romana, Bártů Michaela Kendall, Hájková Nikola, Krkavcová Eva, Flídrová Miroslava, Stružinská Ivana, Němejcová Kristýna, Bouda Jiří, Michalová Květoslava, Cibula David, Poncová Renata, Rys Janusz, Ksiazek Mariusz, Jędryka Marcin, Poprawski Tymoteusz, Berjón Alberto, Zapardiel Ignacio, Laco Jan, Ndukwe Munachiso, Klát Jaroslav, Židlík Vladimír, Krasznai Zoard Tibor, Poka Robert, Zikán Michal, Špůrková Zuzana, Bizoń Magdalena, Sawicki Włodzimierz, Volodko Nataliya, Yezhova Iryna, Ciccarone Francesca, Zinicola Giulia, Bobiński Marcin, Ostrowska-Leśko Marta, Franin Ivan, Kekić Mirela, Piatnytska Tetiana, Varchak Ihor, Pilka Radovan, Marek Radim, Hausnerová Jitka, Koblížková Michaela, Havelka Pavel, Kalist Vladimír, Stukan Maciej, Grabowska Karolina, Kolníková Georgína, Krkoška Milan, Halaška Michael, Drozenová Jana, Stolnicu Simona, Capilna Mihai, Sharashenidze Archil, Gudadze Miranda, Matěj Radoslav, Dundr Pavel

机构信息

Department of Obstetrics and Gynecology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Department of Obstetrics and Gynecology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

出版信息

Lab Invest. 2025 May 24;105(9):104198. doi: 10.1016/j.labinv.2025.104198.

DOI:10.1016/j.labinv.2025.104198
PMID:40419088
Abstract

Low-grade endometrial stromal sarcomas (LG-ESS), high-grade ESS (HG-ESS), undifferentiated uterine sarcomas (UUS), and uterine tumors resembling ovarian sex cord tumors are distinct non-smooth muscle cell neoplasms with varying clinical outcomes, often exhibiting overlapping characteristics. Diagnosis can be supported by identifying characteristic recurrent translocations, which may be absent in some cases, complicating the distinction of equivocal cases. Additionally, cases with overlapping features of low-grade and high-grade characteristics are recognized. To address these challenges, we analyzed RNA-seq profiles of 262 cases. Our results revealed that LG-ESS, with and without recurrent fusions, clustered into 2 partially overlapping expression profiles associated with distinct overall and relapse-free survival outcomes, with the cluster containing a majority of fusion-negative tumors demonstrating better prognoses. uterine tumors resembling ovarian sex cord tumors expression profiles closely resembled those of both LG-ESS subgroups, with NCOA3 fusion-positive cases clustering in groups with better survival outcomes. Furthermore, a distinct cluster for HG-ESS with BCOR and YWHAE fusions was identified, differentiating these tumors from HG-ESS without fusions. ONECUT3 emerged as a potential specific marker for this HG-ESS-fusion entity. A significant expression overlap was observed between monomorphic HG-ESS without fusions and pleomorphic UUS. These samples separated further into 2 mixed clusters distinguished by differences in immune activity, which significantly influenced overall survival and relapse-free survival outcomes. Unsupervised clustering of UUS revealed subgroups resembling either HG-ESS or muscle-cell-differentiated tumors, suggesting that UUS may include poorly differentiated distinct entities, such as leiomyosarcoma, and that the distinction from HG-ESS may, in some cases, be arbitrary. Our transcriptome analysis highlights several entities with distinct survival characteristics, providing a foundation for further characterization of these rare, often difficult-to-classify, tumors.

摘要

低级别子宫内膜间质肉瘤(LG-ESS)、高级别ESS(HG-ESS)、未分化子宫肉瘤(UUS)以及子宫肿瘤样卵巢性索肿瘤是不同的非平滑肌细胞肿瘤,临床结局各异,且常表现出重叠特征。可通过识别特征性的复发性易位来辅助诊断,但某些情况下可能不存在这种易位,这使得鉴别模棱两可的病例变得复杂。此外,还存在具有低级别和高级别特征重叠的病例。为应对这些挑战,我们分析了262例病例的RNA测序图谱。我们的结果显示,无论有无复发性融合的LG-ESS,都聚集成2个部分重叠的表达图谱,与不同的总生存期和无复发生存期结局相关,其中包含大多数融合阴性肿瘤的簇显示出更好的预后。子宫肿瘤样卵巢性索肿瘤的表达图谱与LG-ESS的两个亚组密切相似,NCOA3融合阳性病例聚集在生存结局较好的组中。此外,还识别出了具有BCOR和YWHAE融合的HG-ESS的一个独特簇,将这些肿瘤与无融合的HG-ESS区分开来。ONECUT3成为这种HG-ESS融合实体的一个潜在特异性标志物。在无融合的单形性HG-ESS和多形性UUS之间观察到显著的表达重叠。这些样本进一步分为2个混合簇,其区别在于免疫活性的差异,这显著影响了总生存期和无复发生存期结局。UUS的无监督聚类揭示了类似于HG-ESS或肌肉细胞分化肿瘤的亚组,这表明UUS可能包括分化差的不同实体,如平滑肌肉瘤,并且在某些情况下与HG-ESS的区分可能是随意的。我们的转录组分析突出了几个具有不同生存特征的实体,为进一步表征这些罕见且通常难以分类的肿瘤奠定了基础。

相似文献

1
Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.解读262例子宫肉瘤的分子图谱:子宫内膜间质肉瘤、类似卵巢性索肿瘤的子宫肿瘤及未分化子宫肉瘤的RNA测序聚类分析与预后洞察
Lab Invest. 2025 May 24;105(9):104198. doi: 10.1016/j.labinv.2025.104198.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
6
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.